Welcome to Novo Nordisk in the United States

Brian Hilberdink

Senior Vice President, Commercial Diabetes
Brian Hilberdink, Senior Vice President, Commercial Diabetes

Brian Hilberdink is Senior Vice President, Commercial Diabetes, at Novo Nordisk Inc. since April 15, 2019. He is responsible for leading commercial operations for the diabetes portfolio in the US including sales, brand strategies and initiatives to enhance growth and patient reach.

Mr. Hilberdink is an accomplished pharmaceutical executive with over 20 years of global and domestic experience at Novo Nordisk developing and executing strategy. Before joining Novo Nordisk Inc. in 2019, he was President of Novo Nordisk Canada. As President he significantly increased investment in Canada, launched several innovative products in the therapy areas of diabetes, obesity and hemophilia, and the company was recognized as one of the country’s top 100 employers.

Prior to his work at Novo Nordisk Canada, Mr. Hilberdink was a Corporate Vice President in Global Marketing for Novo Nordisk A/S in Copenhagen, Denmark, leading the launch of the company’s insulin portfolio. He also has experience working at Novo Nordisk in the US, where, from 2003 – 2006, he led several commercial teams during a period of significant growth and investment. 

Mr. Hilberdink holds a bachelor’s degree from the Arts & Science faculty at Queen’s University in Canada, and has completed extensive executive education at multiple universities.